Vienna, Austria

Tamara Nicolson

This inventor holds 1 USPTO granted patent. Top assignee: Thoeris Gmbh. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tamara Nicolson. Retrieved from https://idiyas.com/inventor/tamara-nicolson-wzq0pzg8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tamara Nicolson - Innovator in Fatty Liver Disease Treatment

Introduction

Tamara Nicolson is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of medical science, particularly in the treatment of fatty liver disease. Her innovative approach has garnered attention and recognition in the medical community.

Latest Patents

Tamara Nicolson holds a patent for the "Use of glutamine synthetase for treating fatty liver disease." This invention relates to the administration of glutamine synthetase as a therapeutic option for individuals suffering from this condition. Her work represents a promising advancement in the treatment of fatty liver disease.

Career Highlights

Tamara is associated with Thoeris GmbH, where she applies her expertise in developing innovative solutions for medical challenges. Her dedication to research and development has positioned her as a key player in her field.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Tamara Nicolson's contributions to the treatment of fatty liver disease through her patent demonstrate her commitment to advancing medical science. Her work continues to inspire future innovations in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…